You just read:

Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon

News provided by

Merck KGaA, Darmstadt, Germany

Dec 20, 2018, 07:42 ET